ELEV Logo

Elevation Oncology, Inc. (ELEV) 

NASDAQ
Market Cap
$128.4M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
572 of 809
Rank in Industry
313 of 445

Largest Insider Buys in Sector

ELEV Stock Price History Chart

ELEV Stock Performance

About Elevation Oncology, Inc.

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

Insider Activity of Elevation Oncology, Inc.

Over the last 12 months, insiders at Elevation Oncology, Inc. have bought $0 and sold $0 worth of Elevation Oncology, Inc. stock.

On average, over the past 5 years, insiders at Elevation Oncology, Inc. have bought $26M and sold $2.9M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 187,500 shares for transaction amount of $3M was made by Aisling Capital IV, LP (10 percent owner) on 2021‑06‑29.

List of Insider Buy and Sell Transactions, Elevation Oncology, Inc.

2022-05-25SaleRoyston Aaron
702,737
3.1622%
$4.12$2.9M-69.80%
2021-06-29PurchaseAisling Capital IV, LP10 percent owner
187,500
22.5074%
$16.00$3M-56.00%
2021-06-29PurchasevenBio Global Strategic Fund III, L.P.10 percent owner
625,000
75.0247%
$16.00$10M-56.00%
2021-06-29PurchaseQiming U.S. Healthcare Fund II, L.P.10 percent owner
312,500
37.5123%
$16.00$5M-56.00%
2021-06-29PurchaseVertex Global HC Fund II Pte. Ltd.10 percent owner
250,000
30.0099%
$16.00$4M-56.00%
2021-06-29PurchaseCormorant Asset Management, LP
250,000
30.0099%
$16.00$4M-56.00%

Insider Historical Profitability

<0.0001%
Aisling Capital IV, LP10 percent owner
2834910
6.6838%
$2.3510<0.0001%
venBio Global Strategic Fund III, L.P.10 percent owner
2608167
6.1492%
$2.3510<0.0001%
Qiming U.S. Healthcare Fund II, L.P.10 percent owner
2370142
5.588%
$2.3510<0.0001%
Vertex Global HC Fund II Pte. Ltd.10 percent owner
2307642
5.4407%
$2.3510<0.0001%
Cormorant Asset Management, LP
2233168
5.2651%
$2.3510<0.0001%
Royston Aaron
1905430
4.4924%
$2.3501

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Farallon Capital$19.94M7.113.89MNew+$19.94M0.14
Point72 Asset Management$17.28M6.173.37MNew+$17.28M0.03
Tang Capital Management, LLC$15.7M5.63.06M-16.57%-$3.12M0.06
Balyasny Asset Management Llc$15.67M5.593.06MNew+$15.67M0.04
Aisling Capital Management LP$14.54M5.192.83M0%+$04.98
venBio$13.83M4.932.7M-7.49%-$1.12M4.91
Braidwell Lp$12.2M4.352.38MNew+$12.2M0.69
Darwin Global Management Ltd$11.97M4.272.33MNew+$11.97M1.78
Bvf Inc Il$11.86M4.232.31M0%+$00.09
Citadel Advisors LLC$8.05M2.871.57M+165.36%+$5.02M0.01
The Vanguard Group$7.86M2.81.53M+30.8%+$1.85M<0.0001
Artal Group S A$7.76M2.771.51MNew+$7.76M0.04
Hudson Bay Capital Management LP$7.75M2.771.51M+176.57%+$4.95M0.08
Palo Alto Investors Lp$6.91M2.471.35MNew+$6.91M0.78
Affinity Asset Advisors$6.51M2.321.27MNew+$6.51M1.16
Logos Global Management Lp$5.13M1.831MNew+$5.13M0.55
OrbiMed$4.83M1.72941,275-37.25%-$2.87M0.1
Laurion Capital Management LP$4.56M1.63888,889New+$4.56M0.13
Walleye Capital$4.04M1.44786,584New+$4.04M0.01
Millennium Management LLC$3.43M1.22668,573-77.64%-$11.91M<0.01
Goldman Sachs$2.83M1.01551,079New+$2.83M<0.01
Velan Capital$2.55M0.91497,2990%+$01.39
Sphera Fund$2.21M0.79430,000-52.22%-$2.41M0.37
Geode Capital Management$1.79M0.64348,433+51.4%+$607,017.65<0.0001
GHOST TREE CAPITAL LLC$1.28M0.46250,000New+$1.28M0.42
Bank of America$1.26M0.45245,332+58.82%+$466,127.13<0.0001
Schonfeld Group$905,091.000.32176,431+1,151.28%+$832,758.000.01
BlackRock$881,852.000.32171,901+113.08%+$467,984.18<0.0001
Ikarian Capital LLC$759,697.000.27148,089-87.36%-$5.25M0.22
Qube Research & Technologies$732,179.000.26142,725New+$732,179.00<0.01
JPMorgan Chase$703,882.000.25137,209+56,833.19%+$702,645.67<0.0001
Hrt Financial Llc$683,000.000.24133,268New+$683,000.00<0.01
Marshall Wace$680,731.000.24132,696New+$680,731.00<0.01
UBS$628,758.000.22122,565-4.59%-$30,266.98<0.0001
Man Group Plc$621,920.000.22121,232New+$621,920.00<0.01
Citigroup$613,076.000.22119,508New+$613,076.00<0.01
State Street$567,378.000.2110,600+162.71%+$351,405.00<0.0001
Bridgeway Capital Management$546,345.000.2106,500New+$546,345.000.01
Prelude Capital$514,549.000.18100,302New+$514,549.000.04
Jane Street Capital$404,757.000.1478,900New+$404,757.00<0.0001
Squarepoint Ops LLC$355,514.000.1369,301New+$355,514.00<0.01
Dimensional Fund Advisors$350,625.000.1368,348New+$350,625.00<0.0001
Northern Trust$332,414.000.1264,798+45.5%+$103,954.40<0.0001
Polar Asset Management Partners Inc$280,611.000.154,700New+$280,611.000.01
Boothbay Fund Management LLC$201,999.000.0739,376-84.66%-$1.11M0.01
American Century Investments$162,211.000.0631,620New+$162,211.00<0.0001
Brevan Howard Capital Management Lp$145,477.000.0528,358New+$145,477.000.01
Morgan Stanley$144,010.000.0528,072+719.14%+$126,429.41<0.0001
Bank of Montreal$115,938.000.0422,600New+$115,938.00<0.0001
Y Intercept Hong Kong Ltd$111,860.000.0421,805New+$111,860.000.01